Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2016
Period Ending	Sep '24 Sep 5, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2016
Market Capitalization	15,374	14,014	10,008	14,112	15,526	-	Upgrade
Market Cap Growth	16.57%	40.02%	-29.08%	-9.10%	-	-	Upgrade
Enterprise Value	13,956	12,658	9,443	13,028	13,956	-	Upgrade
Last Close Price	58.08	52.94	41.70	58.80	64.69	-	Upgrade
PE Ratio	-	-48.57	-21.83	-31.28	-47.57	-	Upgrade
PS Ratio	37.72	36.26	33.11	74.13	561.28	-	Upgrade
PB Ratio	9.81	8.52	12.71	11.26	9.18	-	Upgrade
P/FCF Ratio	-209.06	-47.45	-21.81	-26.86	-38.67	-	Upgrade
P/OCF Ratio	1061.69	-60.21	-27.02	-31.04	-45.15	-	Upgrade
EV/Sales Ratio	34.27	32.75	31.24	68.44	504.55	-	Upgrade
EV/EBITDA Ratio	-38.68	-35.66	-19.45	-28.10	-40.28	-	Upgrade
EV/EBIT Ratio	-34.76	-31.85	-17.55	-25.75	-36.61	-	Upgrade
EV/FCF Ratio	-203.28	-42.86	-20.57	-24.80	-34.76	-	Upgrade
Debt / Equity Ratio	0.61	0.54	0.70	0.18	0.03	0.88	Upgrade
Debt / FCF Ratio	-13.93	-3.01	-1.19	-0.43	-0.13	-0.33	Upgrade
Asset Turnover	0.14	0.17	0.18	0.10	0.02	-	Upgrade
Inventory Turnover	0.25	0.30	0.36	0.19	0.04	0.04	Upgrade
Quick Ratio	2.15	2.08	1.57	3.35	11.37	0.53	Upgrade
Current Ratio	2.31	2.22	1.77	3.69	11.85	0.68	Upgrade
Return on Equity (ROE)	-14.78%	-24.27%	-47.59%	-31.38%	-35.20%	-252.11%	Upgrade
Return on Assets (ROA)	-7.80%	-10.91%	-19.70%	-17.02%	-20.80%	-73.37%	Upgrade
Return on Capital (ROIC)	-9.09%	-12.84%	-23.92%	-19.64%	-25.32%	-133.90%	Upgrade
Earnings Yield	-1.50%	-1.99%	-4.57%	-3.20%	-2.06%	-	Upgrade
FCF Yield	-0.45%	-2.11%	-4.59%	-3.72%	-2.59%	-	Upgrade
Buyback Yield / Dilution	-8.53%	-6.74%	0.19%	-2.20%	-30.61%	95.55%	Upgrade
Total Shareholder Return	-8.53%	-6.74%	0.19%	-2.20%	-30.61%	95.55%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.